Skip to main content
logo
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
3.040
-0.035 (-1.14%)
At close: Aug 21, 2026, 4:00 PM EDT
3.130
+0.090 (2.96%)
After-hours: Aug 21, 2026, 7:59 PM EDT

Elicio Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
14.2312.8111.3311.95.637.54
Research & Development
23.6924.933.6623.8518.117.93
Operating Expenses
37.9237.7144.9935.7523.7325.47
Operating Income
-37.92-37.71-44.99-35.75-23.73-25.47
Interest Expense
-1.58-1.13-0.46-1.06-3.6-0.88
Interest & Investment Income
0.690.780.780.370.070
Currency Exchange Gain (Loss)
0.01-0.150.2--
Other Non Operating Income (Expenses)
0.95-1.92-7.390.43-0.95-0.05
EBT Excluding Unusual Items
-37.84-39.99-51.9-35.8-28.21-26.4
Gain (Loss) on Sale of Assets
--0---
Other Unusual Items
-0.42-0.610-
Pretax Income
-37.84-39.57-51.9-35.2-28.21-26.4
Net Income
-37.84-39.57-51.9-35.2-28.21-26.4
Net Income to Common
-37.84-39.57-51.9-35.2-28.21-26.4
Net Income Growth
------
Shares Outstanding (Basic)
1715125015
Shares Outstanding (Diluted)
1715125015
Shares Change
23.82%25.48%141.35%1500.08%-97.93%42.39%
EPS (Basic)
-2.17-2.58-4.25-6.96-89.27-1.73
EPS (Diluted)
-2.17-2.58-4.25-6.96-89.27-1.73
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-37.71-36.97-37.16-32.76-22.83-24.46
Free Cash Flow Per Share
-2.17-2.41-3.04-6.48-72.26-1.60
EBITDA
-37.74-37.51-44.67-35.36-23.34-25.22
D&A For EBITDA
0.180.20.320.380.390.25
EBIT
-37.92-37.71-44.99-35.75-23.73-25.47
SEC Filings: 10-K · 10-Q